3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
55
Neoplasm Metastasis
5
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Uterine Neoplasms
2
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Recurrence
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Neoplasms by Site
1
Neoplasms
1
Malignant Neoplasms of Female Genital Organs
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Liposarcoma
1
Hormone Receptor Positive Breast Carcinoma
1
Head and Neck Neoplasms
1
HR-positive, HER2-negative Breast Neoplasms
1
HER2-positive Metastatic Breast Cancer
1
Genital Neoplasms, Female
1
Genetic Diseases, Inborn
1
Estrogen Receptor Positive Breast Cancer
1
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
1
Disease Progression
1
Interventions
capivasertib
1
Fulvestrant
1
Estrogens
1
Estradiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Estrogen Receptor Positive Breast Cancer
×
Fulvestrant
×
Clear all
NCT01992952
2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2
Active not recruiting
149 enrolled